# clm_37E625A398A2

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 5,946,253,000 United States dollar  
valid_from: 2011-03-31  
valid_to: 2011-06-30  
published: 2011-05-09  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_3834A1B5CB30  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 5,946,253,000 United States dollar", as of 2011-03-31 (until 2011-06-30). Claim clm_37E625A398A2, https://asof.is/claim/clm_37E625A398A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000119312511132405/0001193125-11-132405-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2011, filed 2011-05-09  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000119312511132405/0001193125-11-132405-index.htm (primary, SEC EDGAR 10-Q Q1 FY2011, published 2011-05-09)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 5,863,729,000 United States dollar | valid 2010-12-31 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_37E625A398A2](/claim/clm_37E625A398A2.md) | [clm_B3A3FCFB5B2E](/claim/clm_B3A3FCFB5B2E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.